NationalCDSCO Report Reveals Alarming Contamination Levels In Indian Allergy And Cough SyrupsBY Outlook Web Desk
NationalBharat Biotech Recalls Batch Of Typhoid Vaccines After Being Flagged Over Quality IssuesBY Outlook Web Desk
NationalHimachal Pradesh: How Spurious Drugs Have Brought Bad Name, Regulatory Spotlight On State’s Famed Pharma IndustryBY Ashwani Sharma
NationalIndia Takes Pride In Being ‘Pharmacy Of The World’ But Cough Syrup, Eye Drop Deaths Tell A Different StoryBY Rakhi Bose
NationalUzbekistan Deaths: India Starts Probing Marion Biotech, What We Know So Far Of Syrup ControversyBY Outlook Web Desk
InternationalCentre Starts Probe After WHO Claims Indian Cough Syrups Behind 66 Deaths In The GambiaBY Outlook Web Desk
NationalCDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine CovovaxBY Outlook Web Desk
NationalCovaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 MonthsBY Outlook Web Desk
